6 | Peptides (Polypeptides)IBA
06/2021
-
09/2013 |
6 | Pharmaceutical PreparationsIBA
06/2021
-
03/2013 |
3 | Dendrimers (Dendrons)IBA
06/2021
-
08/2014 |
3 | dendronIBA
06/2021
-
11/2014 |
3 | EnzymesIBA
06/2016
-
08/2014 |
2 | 1-phenyl-3,3-dimethyltriazene (PDT)IBA
07/2021
-
04/2020 |
2 | Reactive Oxygen Species (Oxygen Radicals)IBA
07/2021
-
04/2020 |
2 | Epidermal Growth Factor (EGF)IBA
01/2016
-
09/2015 |
2 | Proteins (Proteins, Gene)FDA Link
03/2015
-
05/2013 |
2 | RNA (Ribonucleic Acid)IBA
03/2015
-
09/2013 |
2 | Doxorubicin (Adriamycin)FDA LinkGeneric
11/2014
-
08/2014 |
2 | Progesterone Receptors (Progesterone Receptor)IBA
03/2004
-
12/2003 |
2 | ProgesteroneFDA LinkGeneric
03/2004
-
12/2003 |
1 | AntioxidantsIBA
07/2021 |
1 | Glutathione (Reduced Glutathione)IBA
07/2021 |
1 | Photosensitizing Agents (Photosensitizers)IBA
07/2021 |
1 | GemcitabineFDA Link
06/2021 |
1 | Antineoplastic Agents (Antineoplastics)IBA
06/2021 |
1 | Gly-Phe-Leu-GlyIBA
06/2021 |
1 | Therapeutic UsesIBA
06/2021 |
1 | ProdrugsIBA
06/2021 |
1 | Liposomes (Liposome)IBA
01/2021 |
1 | LipopeptidesIBA
01/2021 |
1 | Singlet OxygenIBA
04/2020 |
1 | Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric
04/2020 |
1 | LuminolIBA
04/2020 |
1 | Interleukin-6 (Interleukin 6)IBA
12/2017 |
1 | crocinIBA
12/2017 |
1 | Citrate (si)-Synthase (Synthase, Citrate)IBA
12/2017 |
1 | Myosin Heavy Chains (Myosin Heavy Chain)IBA
12/2017 |
1 | Gadolinium DTPA (Magnevist)FDA Link
07/2017 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
07/2017 |
1 | Contrast MediaIBA
07/2017 |
1 | Matrix Metalloproteinase 9 (Gelatinase B)IBA
11/2016 |
1 | hydroxypropyl methacrylateIBA
06/2016 |
1 | CY5.5 cyanine dyeIBA
06/2016 |
1 | DNA (Deoxyribonucleic Acid)IBA
03/2015 |
1 | PlatinumIBA
12/2014 |
1 | Oxaliplatin (Eloxatin)FDA LinkGeneric
12/2014 |
1 | 1,2-cyclohexanediamine (dach)IBA
12/2014 |
1 | CytokinesIBA
09/2013 |
1 | AntigensIBA
09/2013 |
1 | tyrosyltubulin ligaseIBA
05/2013 |
1 | Angiogenesis InhibitorsIBA
03/2013 |
1 | Heparin (Liquaemin)FDA LinkGeneric
03/2013 |
1 | doxorubicin-heparinIBA
03/2013 |
1 | CalreticulinIBA
12/2010 |
1 | Biomarkers (Surrogate Marker)IBA
12/2010 |
1 | GlucocorticoidsIBA
03/2004 |
1 | MineralocorticoidsIBA
03/2004 |
1 | Estrogen ReceptorsIBA
12/2003 |
1 | Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
10/2002 |
1 | Cytochrome P-450 CYP1A1 (CYP1A1)IBA
08/2002 |